Compuware Corporation (CPWR) reported earnings per share of 5 cents in the second quarter of fiscal 2013, compared to 10 cents in the year-ago quarter and 5 cents in the previous quarter. Net income came in at $10.6 million versus $22.7 million in the previous year quarter and $10.5 million in the last quarter.
The earnings in the reported quarter missed the Zacks Consensus Estimate of 6 cents per share.
Total revenue for the quarter came in at $220.6 million, declining 15.4% year over year and 2.5% sequentially.
Software license fees came in at $31.7 million, down 48.7% year over year. Maintenance fees were $102.2 million, down 6.3% annually. Subscription fees amounted to $20.2 million, up nearly 6% from the prior year quarter.
Professional services fees were nearly $46 million, down 13.7% from the previous year period. Application services fees increased 17.1% year over year to $20.5 million.
Operating income totaled $17.2 million, falling approximately by 55% from the previous year quarter. Operating margin declined to 7.8% from 14.6% in the previous year quarter but increased from 7.3% in the previous quarter.
Administrative and general expenses amounted to $38.4 million compared with $42 million in the previous year quarter.
Balance Sheet and Cash Flow
Exiting second quarter of fiscal 2013, cash and cash equivalents amounted to $63.5 million declining from $83.5 million in the last quarter. Long-term debt increased to $59.3 million from $36.5 million at the end of the previous quarter.
Cash flow from operations for the first six months of fiscal 2013 came in at $16.3 million versus $31.8 million in the previous year period.
The company reduced its revenue guidance from $1.04 billion to $1.05 billion to $980 million to $995 million for fiscal 2013 along with earnings per share of 36 cents – 40 cents from 43 cents – 47 cents.
The company projects that the cash flow from operations will be within the range of $150 million -$160 million.
The company currently retains a Zacks #3 Rank, which translates into a short-term ‘Hold’ rating. However, we presently maintain our ‘Neutral’ recommendation on the stock.Read the Full Research Report on CPWR
More From Zacks.com
- Investment & Company Information